Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR68 | Q15743 | 6/20 | 1.00 |
| ▸ | HTR2B | P41595 | 4/20 | 1.00 |
| ▸ | ADORA2A | P29274 | 2/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.63 |
| ▸ | HTR1A | P08908 | 1/20 | 0.63 |
| ▸ | ACKR3 | P25106 | 2/20 | 0.60 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.56 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.56 |
| ▸ | TPH1 | P17752 | 5/20 | 0.51 |
| ▸ | CDK9 | P50750 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29390771 | 0.81 | ADORA2A (0.66) | GPR68HTR2BADORA2AACKR3TSHR | |
| SCHEMBL6727019 | 0.77 | NPSR1 (0.74) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| SCHEMBL3301514 | 0.77 | NPSR1 (0.74) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| Hydrochloric Acid SCHEMBL9247173 | 0.76 | NPSR1 (0.72) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| SCHEMBL9566454 | 0.74 | GPR68 (0.64) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| SCHEMBL8413880 | 0.74 | GPR68 (0.64) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| SCHEMBL30206799 | 0.73 | HTR2B (1.00) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| SCHEMBL14869452 | 0.73 | NPSR1 (0.59) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| SCHEMBL4351104 | 0.71 | NPSR1 (0.57) | GPR68HTR2BADORA2ANPSR1HTR1A | |
| SCHEMBL14869402 | 0.70 | NPSR1 (0.64) | GPR68HTR2BADORA2ANPSR1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345340-A1 | METHODS FOR THE PREVENTION AND TREATEMENT OF POST-OPERATIVE ABDOMINAL ADHESIONS | UNIVERSITY OF ROCHESTER (US) | 2025-11-13 | — | — | US | claimed |
| WO-2023285878-A1 | METHODS FOR DETECTING, TREATING, AND PREVENTING GPR68-MEDIATED OCULAR DISEASES, DISORDERS, AND CONDITIONS | AVIATION-OPHTHALMOLOGY (SE) | 2023-01-19 | — | — | WO | claimed |
| US-20250345340-A1 | METHODS FOR THE PREVENTION AND TREATEMENT OF POST-OPERATIVE ABDOMINAL ADHESIONS | UNIVERSITY OF ROCHESTER (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250345340-A1 | METHODS FOR THE PREVENTION AND TREATEMENT OF POST-OPERATIVE ABDOMINAL ADHESIONS | UNIVERSITY OF ROCHESTER (US) | 2025-11-13 | — | — | US | disclosed |
| US-20250304585-A1 | SULFAMATE BASED COVALENT LIGAND-DIRECTED RELEASE (COLDR) COMPOUNDS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-10-02 | — | — | US | disclosed |
| EP-4540249-A1 | SULFAMATE BASED COVALENT LIGAND-DIRECTED RELEASE (COLDR) COMPOUNDS | Yeda Research and Development Co. Ltd (IL) | 2025-04-23 | — | — | EP | disclosed |
| US-20250099438-A1 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS | UNIVERSITY OF MARYLAND, BALTIMORE | 2025-03-27 | — | — | US | disclosed |
| US-12194027-B2 | Small molecule inhibitors of GPCR GPR68 and related receptors for treating cancer, glioblastoma, and other indications | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2025-01-14 | — | — | US | disclosed |
| US-20240327364-A1 | THERAPEUTIC TARGETING OF GPR68 TO INDUCE FERROPTOSIS | UNIVERSITY OF MARYLAND, BALTIMORE | 2024-10-03 | — | — | US | disclosed |
| US-20240139326-A1 | METHACRYLAMIDES PROTEIN BINDERS AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-05-02 | — | — | US | disclosed |
| WO-2023242845-A1 | SULFAMATE BASED COVALENT LIGAND-DIRECTED RELEASE (CoLDR) COMPOUNDS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-12-21 | — | — | WO | disclosed |
| WO-2023285878-A1 | METHODS FOR DETECTING, TREATING, AND PREVENTING GPR68-MEDIATED OCULAR DISEASES, DISORDERS, AND CONDITIONS | AVIATION-OPHTHALMOLOGY (SE) | 2023-01-19 | — | — | WO | disclosed |
| US-20220202785-A1 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-06-30 | — | — | US | disclosed |
| EP-3955922-A1 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS | University of Maryland, Baltimore (US) | 2022-02-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327364-A1 | THERAPEUTIC TARGETING OF GPR68 TO INDUCE FERROPTOSIS | GPR68, GPR65, GPR84 | GPR68 1/4885HTR2B 4538/4885ADORA2A 777/4885 |
| US-20250099438-A1 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS | GPR68, GPR65, GPR4 | GPR68 1/4885HTR2B 864/4885ADORA2A 900/4885 |
| US-20240139326-A1 | METHACRYLAMIDES PROTEIN BINDERS AND USES THEREOF | STAMBP, HSPBP1, ECPAS | GPR68 3833/4885HTR2B 3777/4885ADORA2A 3929/4885 |
| US-12194027-B2 | Small molecule inhibitors of GPCR GPR68 and related receptors for treating cancer, glioblastoma, and other indications | GPR68, GPR65, GPR4 | GPR68 1/4885HTR2B 864/4885ADORA2A 900/4885 |
| US-20250345340-A1 | METHODS FOR THE PREVENTION AND TREATEMENT OF POST-OPERATIVE ABDOMINAL ADHESIONS | GPR68, GPR65, GPR180 | GPR68 1/4885HTR2B 2615/4885ADORA2A 514/4885 |
| US-20250304585-A1 | SULFAMATE BASED COVALENT LIGAND-DIRECTED RELEASE (COLDR) COMPOUNDS | CASR, NPSR1, GSR | GPR68 1052/4885HTR2B 980/4885ADORA2A 1407/4885 |
| US-20220202785-A1 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS | GPR68, GPR65, GPR4 | GPR68 1/4885HTR2B 864/4885ADORA2A 900/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.